Abstract:Background: Delirium is common in COVID-19 intensive care unit (ICU) patients . Biomarkers for prediction, detection, and monitoring are missing. Unbiased omics analyses are warranted to gain a systems biology view on pathophysiology. Methods: This prospective observational satellite study aims to investigate the proteome signatures of COVID-19 ICU patients, comparing those with delirium to those without. This study was conducted in ICUs of a university hospital between March 2020 and September 2021. ICU patients of legal age with a positive SARS-CoV-2 test were screened daily for oversedation and delirium. Blood samples were taken thrice a week. 457 samples were analyzed using data-independent acquisition mass spectrometry to determine protein levels. A mixed-effects logistic regression model was developed to identify proteins significantly influenced by delirium, accounting for sex and age as confounders. This model also aimed to determine proteins that were either up- or downregulated in association with delirium. Additionally, an enrichment analysis was conducted to examine the biological pathways linked to these delirium-associated proteins. Results: Out of 360 ICU patients, 69 were analyzed for protein profiling. Out of these 69 patients, 42 patients (60.9%) had delirium on ICU admission, and 27 (39.1%) did not. Based on the multivariate model, the analysis of 204 proteins unfolded 125 (61.3%) to be differentially expressed. In total, 80.8% (n=101) of these 125 proteins were associated with delirium. Of these, 10 proteins were uniquely associated with delirium and were not significant in the multivariate model (SERPING1, SERPINA7, HP, TGFBI, CD5L, IGHV3-7, IGHV1-46, IGHV3-15, IGHV3-23, and IGHV4-34;IGHV4-38-2). In the univariate model for delirium, six out of 111 significant proteins showed increased expression with a log2FC > 0.5: PIGR, MST1, LBP, CRP, SAA1, and SAA1;SAA2; while three showed decreased expression with a log2FC < -0.5: HP, PPBP, and HP;HPR. The enrichment analysis of delirium-influenced proteins revealed three significant pathways: Network map of SARS-CoV-2 signaling (M42569/WP5115), Acute inflammatory response (M10617), and Regulation of defense response (M15277). Conclusion: We identified a unique proteomic signature in COVID-19 ICU patients with delirium, including up- and downregulated proteins. These findings may provide potential biomarker candidates for the assessment of delirium risk and its underlying causes. These findings could be a further step towards the development of personalized, causative treatments for delirium and its monitoring in the ICU. Trial registration: The study was retrospectively registered in the German Clinical Trials Register on May 13, 2020 (DRKS00021688). Keywords: delirium, intensive care medicine, proteomics, COVID-19, high-throughput mass spectrometry, pathway analysis

Extracellular Vesicles as Possible Plasma Markers and Mediators in Patients with Sepsis-Associated Delirium—A Pilot Study

Diagnostic Potential of Plasma Extracellular Vesicle Mir-483-3p and Let-7d-3p for Sepsis.

Circulating extracellular vesicles are associated with the clinical outcomes of sepsis

Dysregulation of MicroRNAs Derived from Plasma Extracellular Vesicles in Schizoaffective Disorder

Endothelial glycocalyx-associated molecules as potential serological markers for sepsis-associated encephalopathy: A systematic review and meta-analysis

Prediction of Pulmonary Edema by Plasma Protein Levels in Patients with Sepsis.

Extracellular vesicles in sepsis plasma mediate neuronal inflammation in the brain through miRNAs and innate immune signaling

Identification of a panel of serum protein markers in early stage of sepsis and its validation in a cohort of patients

Elevated Level of Small Extracellular Vesicles in the Serum of Patients With Depression, Epilepsy and Epilepsy with Depression

A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of patients with sepsis

Extracellular proteins as potential biomarkers in Sepsis-related cerebral injury

Insights into Organ Dysfunction and Potential Biomarkers

Plasma markers of COVID-19 severity: a pilot study

Elevated extracellular particle concentration in plasma predicts in-hospital mortality after severe trauma

Protein content of blood-derived extracellular vesicles: An approach to the pathophysiology of cerebral hemorrhage

Proteomic profile of extracellular vesicles from plasma and CSF of multiple sclerosis patients reveals disease activity-associated EAAT2

Unique proteome signatures in ICU patients with COVID-19 and delirium: an observational study

Decrease of exosomal miR-21-5p and the increase of CD62p+ exosomes are associated with the development of sepsis in polytraumatized patients

Biomarkers of Endothelial Cell Activation in Early Sepsis

Early Analysis of Endothelial Markers to predict Sepsis in the Emergency Department

LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis